Sydney Lupkin
- Indexed articles, last 90 days
- 12
- Latest publication
- Sep 24, 2026
- Outlet visibility, for Jefferson Public Radio
- Top 5M sites
- Earliest in this view
- Jul 14, 2026
Latest articles
President Trump's FDA commissioner nom, Dr. Heidi Overton, faces Senators' questions (opens the original)
Read excerpt
President Trump has nominated Dr. Heidi Overton to be the new commissioner of the Food and Drug Administration. She faced questions from a Senate committee today as part of the confirmation process. NPR's pharmaceuticals correspondent Sydney Lupkin reports. SYDNEY LUPKIN, BYLINE: Overton was questioned by senators for around two hours. Senators asked her about abortion pill access and safety, vaccines, autism and recent foodborne illness outbreaks. She was also grilled on whether she would be ab
RFK Jr.'s ethics filing reveals book deals worth millions of dollars (opens the original)
Read excerpt
For stories on the science of healthy living, subscribe to NPR's Health newsletter. In the minutes before Health Secretary Robert F. Kennedy Jr. took the stage last Thursday at an anti-vaccine conference in Washington, D.C., MAHA Institute President Mark Gorton was calling vaccines "a public health disaster." The conference was for Children's Health Defense, an anti-vaccine group that has filed dozens of lawsuits against federal agencies, state governments and companies over vaccine requirements
RFK Jr.'s ethics disclosure reveals free travel and hefty book advances (opens the original)
Read excerpt
NPR has gotten a look at Health and Human Services Secretary Robert F. Kennedy Jr.'s latest annual financial disclosure. Disclosures are required of high-ranking federal officials to guard against conflicts of interest. NPR pharmaceuticals correspondent Sydney Lupkin is here to tell us what she's learned. Hey, Sydney. DETROW: What caught your eye in these filings? LUPKIN: Yeah, the biggest items were two book advances Kennedy received in the last year - $2 million apiece from Skyhorse Publishing
A year ago, President Trump pledged to lower Medicaid drug prices. Has that happened? (opens the original)
Read excerpt
When President Trump talks about accomplishments of his second term, he often mentions the deals he's struck with pharmaceutical companies to lower drug prices. "We went from the highest prescription drug prices, by far, anywhere in the world, to the lowest prescription drug prices anywhere in the world," Trump said during his remarks at the midterm Republican National Convention in Dallas on Sept 10. "And that alone should get us a big victory in our midterms that are coming up." Last year on S
Ethics watchdogs await RFK Jr.'s financial report (opens the original)
Read excerpt
Every year, high-ranking federal officials have to file financial reports disclosing their business ties and what assets they own. This is meant to ensure that they don't put their personal interests ahead of the U.S. citizens they serve. The deadline to file the papers was back in May, but ethics officials still have not released the filings for several of President Trump's Cabinet members. One of them is Health Secretary Robert F. Kennedy Jr. NPR pharmaceuticals correspondent Sydney Lupkin has
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Jefferson Public Radio, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.